4-(2-Methyloxazol-4-yl)benzenesulfonamide

Catalog No. :
ACGEDS507
CAS No. :
1099660-84-0
Molecular Formula :
C10H10N2O3S
Molecular Weight :
238.27

IUPAC Name:4-(2-methyloxazol-4-yl)benzenesulfonamide

4-(2-Methyloxazol-4-yl)benzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$165.00Login to see priceInquiryInquiry
100mg95%$237.00Login to see priceInquiryInquiry
250mg95%$331.00Login to see priceInquiryInquiry
1g95%$745.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-Methyloxazol-4-yl)benzenesulfonamide
IUPAC Name4-(2-methyloxazol-4-yl)benzenesulfonamide
MDL No.MFCD11650733
Molecular FormulaC10H10N2O3S
Molecular Weight238.27
SMILESO=S(C1=CC=C(C2=COC(C)=N2)C=C1)(N)=O
InChI KeyGDJABEHUCJHRDC-UHFFFAOYSA-N
Synonym4-(2-Methyloxazol-4-yl)benzenesulfonamide;4-(2-methyl-1,3-oxazol-4-yl)benzene-1-sulfonamide;Benzenesulfonamide, 4-(2-methyl-4-oxazolyl)-
CAS No.1099660-84-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGEDS507 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXEPD093 route compound structure diagram
    ACXEPD093701-34-8 In Stock
  4. Then
  5. ACGEDS507 route product structure diagram
    ACGEDS5071099660-84-0
Inquiry

2. ACGEDS507 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHOXZ798 route compound structure diagram
    ACHOXZ798214360-51-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGEDS507 route product structure diagram
    ACGEDS5071099660-84-0
Inquiry

Comments (0)